Loading...
Market
Global adoption level of ArkeabioTM vaccine by 2025
4
Resolution / Starting Odds
Adopted in 1-5 countries • 25%
Adopted in 6-10 countries • 25%
Adopted in 11-20 countries • 25%
Adopted in 21 or more countries • 25%
Industry reports and adoption metrics
Story
Bill Gates' Fund Backs $26.5M Raise for Cow Methane Vaccine by ArkeabioTM
May 10, 2024, 07:48 AM
A startup has developed a new vaccine aimed at reducing methane emissions from cows by targeting their digestive processes. The vaccine, which has raised $26.5 million in venture capital funding, including a significant contribution from a fund led by Bill Gates, seeks to diminish methane emissions by altering the gut microbiology of livestock. AgriZeroNZ invested $6m in the U.S. startup ArkeabioTM to support this initiative. This effort is part of broader strategies to address the environmental impact of methane emissions from agriculture, with other methods also being explored to reduce emissions from rice farming.
View original story
Similar markets
1-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
more than 30 countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
Fewer than 10 countries • 33%
10-20 countries • 33%
More than 20 countries • 34%
Over 50% vaccination rate • 25%
30-50% vaccination rate • 25%
10-30% vaccination rate • 25%
Under 10% vaccination rate • 25%
Less than 10 • 33%
10 to 20 • 33%
More than 20 • 33%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Low adoption (few countries) • 25%
Moderate adoption (some countries) • 25%
High adoption (many countries) • 25%
Very high adoption (most major livestock countries) • 25%
Widely adopted • 25%
Moderately adopted • 25%
Rarely adopted • 25%
Not adopted • 25%
Over 50 countries • 25%
30-50 countries • 25%
10-29 countries • 25%
Under 10 countries • 25%
Less than 20 countries • 33%
20-50 countries • 34%
More than 50 countries • 33%
Widely adopted in over 50 countries • 25%
Adopted in 20-50 countries • 25%
Adopted in less than 20 countries • 25%
Not adopted widely • 25%